Information  X 
Enter a valid email address

Valereum Blockchain (VLRM)

  Print   

Wednesday 10 November, 2021

Valereum Blockchain

Notice of Exercise of Warrants

RNS Number : 9853R
Valereum Blockchain PLC
10 November 2021
 

10 November 2021

Valereum Blockchain Plc

("Valereum" or the "Company")

 

Notice of Exercise of Warrants

Valereum Blockchain Plc (AQSE: VLRM), the Gibraltar based blockchain technology group , has received exercise notice of warrants for 1,000,000 new ordinary shares of 0.1 pence each with an exercise price of 10 pence each and 1,200,000 new ordinary shares of 0.1 pence each with an exercise price of 8.125 pence each ("Ordinary Shares"). The total exercise consideration is £197,500 and the proceeds will be used by the Company for general working capital purposes.

Application will be made for the Ordinary Shares to be admitted to trading on the AQSE Growth Market and dealings are expected to commence on or around 15 November 2021.

Following the admission of the Ordinary Shares, the Company's total issued and voting share capital will comprise of 73,598,453 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company.

The Directors of the Company accept responsibility for the contents of this announcement.

END

Enquiries:

 

Valereum Blockchain Plc

Richard Poulden, Chairman

Tel: +971 4584 6284

 

AQSE Corporate Adviser

Peterhouse Capital Limited

Mark Anwyl

Tel: +44 (0) 207 469 0930

 

Investor Relations

J&H Communications Limited

James Henderson

Tel: +44 (0)7774 444163

[email protected]

 

George Hudson

Tel: +44 (0)7803 603130

[email protected]

 

The website address of the Company is   www.valereumblockchain.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEALFEFFPFFFA

a d v e r t i s e m e n t